Drug Recall Lawyer Blog- Santarus files for approval to FDA for anti-swelling drug Rhucin.
- Prescription Drug Coverage Is an Important Part of Your Health Care: Medicare Part D Needs to be Considered.
- Bone-Damage Concerns Lead to Halt of Pain-Drug Tests -Bloomberg
- FDA Needs Four More Weeks to Review MannKind’s Diabetes Drug Afrezza.
Published on:
News Roundup
